Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Bet1 golgi vesicular membrane trafficking protein (BET1) is an integral vesicular SNARE protein encoded by BET1 gene, widely distributed across secretory cell populations, localized exclusively to COPII vesicle and cis-Golgi membrane surfaces. Distinct from other SNARE paralogs, BET1 relies on conserved transmembrane and coiled-coil domains to mediate SNARE complex assembly, while simultaneously controlling accurate vesicle docking and cargo delivery from endoplasmic reticulum to Golgi compartments. Under resting secretory status, basal BET1 expression sustains steady-state constitutive cargo transport without aberrant vesicle fusion. Upon enhanced secretory demand, elevated BET1 incorporation into vesicle membranes accelerates SNARE complex formation to facilitate directional cargo shuttling along the anterograde transport axis. Unlike ubiquitous SNARE proteins with broad intracellular trafficking roles, BET1 bears specialized ER-Golgi vesicle docking functions that cannot be fully compensated by other SNARE family members, linking vesicle membrane assembly directly to canonical secretory transport pathways. Loss of functional BET1 severely disrupts ER-to-Golgi cargo delivery and blocks mature secretory protein maturation, while excessive BET1 expression accelerates uncontrolled vesicle fusion, establishing BET1 as a core research target for SNARE biology and secretory modulator screening.
BET1 executes core vesicular SNARE docking function embedded within transport vesicle lipid bilayers, utilizing conserved coiled-coil structural motifs to drive selective pairing with cis-Golgi target SNARE partners. Conserved interaction domains exclusively engage ER-Golgi cognate SNARE subunits, separating its binding spectrum from post-Golgi trafficking SNARE molecules. BET1-mediated complex assembly bridges ER cargo packaging and Golgi compartment delivery, balancing vesicle transport efficiency and fusion fidelity according to cellular secretory load. BET1 participates in extensive physiological processes including constitutive protein secretion, membrane protein maturation and invasive cell surface cargo delivery. Deficient BET1 expression disrupts anterograde vesicle trafficking and impairs secretory protein maturation. Therefore, BET1 represents a pivotal research target for intracellular transport protein study and secretory pathway inhibitor screening.
Fig. 1 Co-immunoprecipitation assay demonstrating BET1 interacts with cis-Golgi SNARE partners to form functional SNARE complexes.1
The biological functions of BET1 are focused on SNARE complex pairing, vesicle docking and secretory cargo regulation:
Creative Biolabs offers high-quality BET1 proteins through optimized expression systems, including full-length vesicular SNARE protein and isolated coiled-coil domain variants. These products retain native SNARE pairing capacity, suitable for vesicle interaction and secretory modulator screening. All BET1 proteins undergo strict quality control to ensure consistent performance and reliable application across diverse research platforms.
Not finding the membrane protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides custom-engineered BET1 stable cell lines, including overexpression and blank control models. These cell lines are optimized for SNARE expression profiling and vesicle trafficking functional analysis. Each cell line undergoes stringent validation to ensure stable expression profiles and consistent functional performance in diverse experimental contexts.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
High-specificity recombinant antibodies targeting BET1 are developed via advanced antibody engineering technologies, with no cross-reactivity with other vesicular SNARE paralogs. These antibodies are validated for transport vesicle membrane localization detection and secretory tissue profiling, and can be combined with Golgi marker reagents to analyze complete BET1 SNARE complexes in biosynthetic cell models.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for BET1 research:
BET1 is a vesicular SNARE protein that mediates ER-derived vesicle docking and SNARE complex assembly for anterograde cargo transport to Golgi.
BET1 acts as a critical link between ER cargo packaging and cis-Golgi delivery, governing global secretory protein maturation.
No, all BET1 products and services are strictly for research use only, not intended for clinical diagnosis or treatment.
Offerings include full-length BET1 SNARE proteins, isoform-specific detection antibodies and custom stable cell lines for vesicle trafficking research.
BET1 proteins are validated via SNARE heterocomplex binding functional testing.
